Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer. [electronic resource]
Producer: 20101203Description: 212-8 p. digitalISSN:- 1873-4995
- Animals
- Antibiotics, Antineoplastic -- administration & dosage
- Breast -- drug effects
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Survival -- drug effects
- Delayed-Action Preparations -- chemistry
- Doxorubicin -- administration & dosage
- Female
- Humans
- Hyaluronic Acid -- chemistry
- Rats
- Rats, Sprague-Dawley
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.